Found: 9
Select item for more details and to access through your institution.
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 5, p. 1808, doi. 10.1007/s10620-023-08252-1
- By:
- Publication type:
- Article
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 9, p. 1324, doi. 10.1038/ajg.2015.233
- By:
- Publication type:
- Article
Editorial: biologic therapies for primary sclerosing cholangitis—more disappointment than promise? Authors’ reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 2, p. 190, doi. 10.1111/apt.14829
- By:
- Publication type:
- Article
Comparison of infliximab with adalimumab in 827 biologic‐naïve patients with Crohn's disease: a population‐based Danish cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 596, doi. 10.1111/apt.14466
- By:
- Publication type:
- Article
Postoperative outcomes in vedolizumab‐treated Crohn's disease patients undergoing major abdominal operations.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 573, doi. 10.1111/apt.14459
- By:
- Publication type:
- Article
Letter: the definition of budesonide dependence in microscopic colitis-authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 6, p. 636, doi. 10.1111/apt.14239
- By:
- Publication type:
- Article
The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 1, p. 32
- By:
- Publication type:
- Article